维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="SADONES J"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Stratified phase Ⅱ trial of cetuximab in patients with recurrent high-grade glioma显示文摘	Neyns B Sadones J Joosens E	2009	Ann Oncol2009，20，：	1
	2	MGMT promoter hyperm-ethylation correlates with a survival benefit from temozolomide inpatients with recurrent anaplastic astrocytoma but not glioblastoma显示文摘	Sadones J Michotte A Veld P	2009	Eur J Cancer2009，45，1：	1
	3	MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma显示文摘	SADONES J MICHOTTE A VELD P	2009	Eur J Cancer2009，45，1：	1
	4	Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma显示文摘	Lv S Teugels E Sadones J	2011	Anticancer Res2011，31，12：	1
	5	Correlation of EGFR,IDH1 and PTEN status with the outcome of patients'with recurrent glio blastoma treated in a phase 1I clinical trial with the EGFR-bloc- king monoclonal antibody cetuximab 显示文摘	Lv S Teugels E Sadones J	2012	Int J Oncol2012，41，3：	1
	6	Phase Ⅱ study of sunitinib malate in patients with recurrent high-grade glioma 显示文摘	Neyns B Sadones J Chaskis C et ol	2011	J Neurooncol2011，103，3：	1
	7	Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma显示文摘	Neyns B Sadones J Joosens E	2009	Ann Oncol2009，20，9：	1
	8	Correlation of EGFR,IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab显示文摘	Lv S Teugels E Sadones J	2012	Int J Oncol2012，41，3：	1
	9	MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma显示文摘	Sadones J Michotte A Veld P	2009	Eur J Cancer2009，45，1：	1
	10	MGMT promoter hy- permethylation correlates with a survival benefit from temozo- lomide in patients with recurrent anaplastic astrocytoma but not glioblastoma显示文摘	Sadones J Michotte A Veld P	2009	Eur J Cancer2009，45，1：	1
	11	Correlation of EGFR,IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab显示文摘	Lv S Teugels E Sadones J		0，，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费